|
Sun Pharmaceutical Industries Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
428137.33 Cr.
|
P/BV
|
6.19
|
Book Value (Rs.)
|
288.06
|
|
52 Week High/Low (Rs.)
|
1960/1377
|
FV/ML
|
1/1
|
P/E(X)
|
44.71
|
|
Bookclosure
|
06/02/2025
|
EPS (Rs.)
|
39.91
|
Div Yield (%)
|
0.76
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 47758.45 | 43278.87 | 38426.42 | 33139.18 | 32325.17 |
| Other Operating Revenues | 738.40 | 606.81 | 228.07 | 358.96 | 512.33 |
| Total Operating Revenues | 48496.85 | 43885.68 | 38654.49 | 33498.14 | 32837.50 |
| | | | | | |
| Other Income | 1354.19 | 634.52 | 921.51 | 835.52 | 635.98 |
| Total Revenue | 49851.04 | 44520.20 | 39576.00 | 34333.66 | 33473.48 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 6904.33 | 7777.57 | 7049.12 | 6153.13 | 5515.23 |
| Purchase Of Stock-In Trade | 3466.15 | 3571.50 | 3410.03 | 3175.17 | 3414.37 |
| Operating And Direct Expenses | 630.26 | 561.32 | 557.81 | 0.00 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 292.13 | -686.91 | -107.61 | -638.22 | 300.85 |
| Employee Benefit Expenses | 9429.06 | 8296.03 | 7300.83 | 6862.23 | 6362.35 |
| Finance Costs | 238.47 | 172.00 | 127.35 | 141.43 | 302.73 |
| Depreciation And Amortisation Expenses | 2556.64 | 2529.43 | 2143.74 | 2079.95 | 2052.78 |
| Other Expenses | 14751.79 | 12719.38 | 10046.59 | 9454.46 | 10254.94 |
| Total Expenses | 38268.83 | 34940.32 | 30527.86 | 27228.15 | 28203.25 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 11582.21 | 9579.88 | 9048.14 | 7105.51 | 5270.23 |
| | | | | | |
| Exceptional Items | -494.32 | -171.45 | -4566.82 | -4306.14 | -260.64 |
| Profit/Loss Before Tax | 11087.89 | 9408.43 | 4481.32 | 2799.37 | 5009.59 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1989.30 | 1869.22 | 354.39 | 957.30 | 1320.14 |
| Deferred Tax | -549.85 | -1021.63 | 721.11 | -442.61 | -497.34 |
| Total Tax Expenses | 1439.45 | 847.59 | 1075.50 | 514.69 | 822.80 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 9648.44 | 8560.84 | 3405.82 | 2284.68 | 4186.79 |
| | | | | | |
| Profit/Loss From Continuing Operations | 9648.44 | 8560.84 | 3405.82 | 2284.68 | 4186.79 |
| | | | | | |
| Profit/Loss For The Period | 9648.44 | 8560.84 | 3405.82 | 2284.68 | 4186.79 |
| | | | | | |
| Minority Interest | -33.65 | -39.36 | -116.55 | 631.47 | -407.03 |
| Share Of Profit/Loss Of Associates | -38.41 | -47.90 | -16.54 | -12.33 | -14.83 |
| Consolidated Profit/Loss After MI And Associates | 9576.38 | 8473.58 | 3272.73 | 2903.82 | 3764.93 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 39.90 | 35.30 | 13.60 | 12.10 | 15.70 |
| Diluted EPS (Rs.) | 39.90 | 35.30 | 13.60 | 12.10 | 15.70 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 2898.16 | 2519.30 | 2158.91 | 1559.06 | 1378.96 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 283.45 |
